Surgery – Diagnostic testing
Reexamination Certificate
2006-07-11
2006-07-11
Nasser, Robert L. (Department: 3736)
Surgery
Diagnostic testing
C600S481000
Reexamination Certificate
active
07074183
ABSTRACT:
Methods for treating vascular disease in humans and generating data representing treatment plans are disclosed. A first set of clinical vascular health data from a healthcare provider and representing a vascular health condition of a patient is received at a data center server that is communicatively coupled to a public data network. One or more vascular disease analysis algorithms are applied to the first set of vascular health data, to result in creating and storing an initial treatment plan for the patient. A second set of vascular health data is received from a monitoring device that is associated with the patient and that is communicatively coupled to the data network; the second set of data include Doppler monitor data obtained from the peripheral vascular system of the patient. One or more vascular analysis algorithms are applied to result in creating one or more supplementary treatment plans for the patient. At least one of the treatment plans includes a biofeedback interaction. The treatment plans are provided to the patient over the data network. The foregoing steps are iteratively repeated one or more times as determined by the physician and patient, resulting in improved vascular health.
REFERENCES:
patent: 4601292 (1986-07-01), Fidel et al.
patent: 4745924 (1988-05-01), Ruff
patent: 4802458 (1989-02-01), Finsterwald et al.
patent: 4860759 (1989-08-01), Kahn et al.
patent: 4967753 (1990-11-01), Haase et al.
patent: 5195519 (1993-03-01), Angelsen
patent: 5277187 (1994-01-01), Pillsbury
patent: 5357427 (1994-10-01), Langen et al.
patent: 5409009 (1995-04-01), Olson
patent: 5409010 (1995-04-01), Beach et al.
patent: 5529073 (1996-06-01), Kielbasiewicz
patent: 5666404 (1997-09-01), Ciccotelli et al.
patent: 6319201 (2001-11-01), Wilk
patent: 6454712 (2002-09-01), Oonuki
patent: 6612985 (2003-09-01), Eiffert et al.
patent: 6712762 (2004-03-01), Lichter et al.
patent: 2002/0035316 (2002-03-01), Drazen
patent: 2002/0188182 (2002-12-01), Haines et al.
patent: 2003/0036683 (2003-02-01), Kehr et al.
patent: 2003/0208108 (2003-11-01), Shewmake et al.
patent: 2003/0212579 (2003-11-01), Brown et al.
patent: 2004/0034288 (2004-02-01), Hennessy et al.
Deborah F. Tate PhD, et al., “Using Internet Technology to Deliver a Behavioral Weight Loss Program,” JAMA, Mar. 7, 2001, vol. 285, No. 9, p. 1172-1177.
Nancy Walsh, “Meditation Program Linked to Reduction in Carotid Intima-Media Thickness,” Mar. 1, 2001, Family Practice News, p. 15.
Spacelabs Medical—Products, http://www.spacelabs.com/products/index.html, printed Jan. 17, 2000.
M. Zoler, “Framingham Score Drives Coronary Prevention,” 34 eFamily Practice News (Mar. 1, 2004).
K. Rother, “Framingham Heart Study analysis reveals some primary prevention subgroups are being overlooked” (theheart.org, Oct. 2004).
A. Cohen et al., “A categorization and analysis of the criticisms of Evidence-Based Medicine,” 11 Int'l J. of Medical Informatics 2 (2003).
Hartley, Carolyn P. et al., “A New Look at Disease Management,” The Physician's eHealth Report, vol. 2.6 Nov./Dec. 2005, 12 pages.
Haynes, R et al., “Interventions to enhance medication adherence,” Abstract, Cochrane Database Syst Rev 2005 Oct. 19; (4):CD000011.
Kaushik, R et al., “Biofeedback assisted diaphragmatic breathing and systematic relaxation versus propranolol in long term prophylaxis of migraine,” Abstract, Complement Ther Med 2005 Sep.;13(3):165-74.
Krueger, KP et al., “Improving adherence and persistence: a review and assessment of interventions and description of steps toward a national adherence initiative,” Abstract, J Am Pharm Assoc (Wash DC), Nov.-Dec. 2003; 43(6):668-78.
McDonald, HP et al., “Interventions to enhance patient adherence to medication prescriptions: scientific review,” Abstract, JAMA Dec. 11, 2002; 288(22):2868-79.
McGinnis, RA et al., “Biofeedback-assisted relaxation in type 2 diabetes,” Abstract, Diabetes Care Sep. 28, 2005;(9):2145-9.
Medicine Avenue, Inc., products description, located on the internet at <http://www.healtheheart.com>, retrieved on Jan. 3, 2004, 2 pages.
Nolan, RP et al., “Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control,” Abstract, 1: Am Heart J Jun. 2005:149(6):1137.
Pittler, MH et al., “Complementary therapies for peripheral arterial disease: systematic review,” Abstract, 1 Atherosclerosis Jul. 2005; 181(1):1-7, Mar. 31, 2005.
Runck, B., “What is Biofeedback?”DHHS Pub. No. (ADM) 83-1273, reprinted online by Arizona Behavioral Health Associates, P.C., date unknown, 5 pages.
Silverman, J., “Partnership Between Physician and Patient is Key to Successful Compliance,” 34 eFamily Practice News 1, Jan. 1, 2004, 1 page.
Stefano, GB et al., “Integrative medical therapy: examination of meditation's therapeutic and global medicinal outcomes via nitric oxide (review),” Abstract, Int J Mol Med Oct. 2005;16(4):621-30.
Nolan, RP et al., “Heart rate variability biofeedback as a behavioral neurocardiac intervention to enhance vagal heart rate control,” Abstract, 1: Am Heart J Jun 2005:149(6):1137.
Tindle, Ha et al., “Factors associated with the use of mind body therapies among United States adults with musculoskeletal pain,” Abstract, Complement Ther Med Sep. 2005: 13(3):155-64.
Castellanos Alexander F.
Hickman Palermo & Truong & Becker LLP
Nasser Robert L.
LandOfFree
Method and system for improving vascular systems in humans... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method and system for improving vascular systems in humans..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method and system for improving vascular systems in humans... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3546293